Source / episode info

• **Episode:**232
• **Title:**Divine Intervention Episode 232 – Vasculitis and The USMLE.
• **Published:**2020-04-30
• Source:Episode page

One-liner

Episode 232 provides a comprehensive review of vasculitis, detailing the pathophysiology (immune complex deposition), classifying diseases by vessel size (large: Takayasu/GCA; medium: PAN/Kawasaki/Buerger's; small: HSP/Cryoglobulinemia), and highlighting key diagnostic criteria, management protocols, and high-yield associations for board exams.

High-yield summary

• Classification: Vasculitis is defined as inflammation of blood vessels (arteries, arterioles, capillaries, venules, or veins). Classification by vessel size (large, medium, small) helps narrow the differential diagnosis.
• Goodpasture Syndrome: Characterized by autoantibodies against Type IV collagen in the glomerulus and alveolar basement membrane. Diagnosis is supported by linear immunofluorescence pattern and clinical triad of pulmonary hemorrhage/glomerulonephritis.
• Giant Cell Arteritis (GCA): Typically affects women > 50 years old, presenting with headache, jaw claudication, and elevated ESR. Management requires immediate high-dose corticosteroids, followed by a temporal artery biopsy within three days.
• Takayasu Arteritis: A large vessel vasculitis classically affecting the aorta and its major branches (subclavian/carotid). The classic presentation is in young women (<50 years old) from Asia, often presenting with differential blood pressures between arms ("string of beads" appearance on angiography).
• Henoch-Schönlein Purpura (HSP): A small vessel vasculitis characterized by palpable purpura, typically located below the buttocks. It is associated with IgA deposition and frequently presents in children with abdominal pain and joint pain.
• Polyarteritis Nodosa (PAN): A medium vessel vasculitis strongly associated with Hepatitis B/C infection. Crucially, PAN does not involve the lungs.

Learning objectives

• Differentiate between vasculitis types based on vessel size and associated antibodies (e.g., anti-Type IV collagen vs. anti-MPO).
• Recognize the classic clinical presentations and demographics for large, medium, and small vessel vasculitides (Takayasu, GCA, PAN, HSP).
• Understand the pathophysiology of immune complex deposition in various vasculitis syndromes (e.g., IgA in HSP; Type IV collagen in Goodpasture).
• Master the acute management protocols for high-risk vasculitides, such as GCA and Kawasaki disease.
• Identify critical associations, such as the link between Hepatitis C/B and PAN or cryoglobulinemia.